Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:2376231.
doi: 10.1155/2017/2376231. Epub 2017 Jan 16.

Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists

Affiliations
Review

Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists

Liping Guo et al. Gastroenterol Res Pract. 2017.

Abstract

Autoimmune liver diseases (AILDs) often coexist with other extrahepatic autoimmune diseases (EHAIDs). The spectrum of EHAIDs in patients with AILDs is similar, whereas the incidence is different. Notably, autoimmune thyroid disease and Sjogren's syndrome are the most common EHAIDs. Associated extrahepatic diseases may predate the appearance of AILDs or coincide with their onset. More frequently, they may appear during the course and even occur years after the diagnosis of AILDs. Importantly, associated EHAIDs may influence the natural course and prognosis of AILDs. To date, a definite pathophysiological pathway which contributes to the coexistence of AILDs and EHAIDs is still lacking. The current view of autoimmunity clustering involves a common susceptibility genetic background which applies to related pathologies. Herein, we review the current published researches regarding EHAIDs in patients with AILDs, particularly in relation to their clinical impact and pathophysiology. In managing patients with AILDs, gastroenterologists should be aware of the possibly associated EHAIDs to ensure a prompt diagnosis and better outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Watt F. E., James O. F. W., Jones D. E. J. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM. 2004;97(7):397–406. doi: 10.1093/qjmed/hch078. - DOI - PubMed
    1. Pamfil C., Candrea E., Berki E., Popov H. I., Radu P. I., Rednic S. Primary biliary cirrhosis—autoimmune hepatitis overlap syndrome associated with dermatomyositis, autoimmune thyroiditis and antiphospholipid syndrome. Journal of Gastrointestinal and Liver Diseases. 2015;24(1):101–104. - PubMed
    1. Kurihara Y., Shishido T., Oku K., et al. Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura. Modern Rheumatology. 2011;21(3):325–329. doi: 10.1007/s10165-010-0397-0. - DOI - PubMed
    1. Hatzis G. S., Fragoulis G. E., Karatzaferis A., Delladetsima I., Barbatis C., Moutsopoulos H. M. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. Journal of Rheumatology. 2008;35(10):2012–2016. - PubMed
    1. Hua R., Wu H., Zhang X. W., Sun Y. W. Probable catastrophic antiphospholipid syndrome complicated with primary sclerosing cholangitis. Journal of Digestive Diseases. 2012;13(11):601–603. doi: 10.1111/j.1751-2980.2012.00614.x. - DOI - PubMed

LinkOut - more resources